Table 2 Comparison of adverse pregnancy outcomes between the group of high level and normal group of inhibin-A level

381 (8.3%)

25 (12.2%)

1.51 (1.01–2.26)

0.049

19 (6.9%)

0.83 (0.53–1.31)

0.420

324 (7.0%)

11 (5.4%)

0.76 (0.42–1.37)

0.356

15 (5.5%)

0.77 (0.46–1.28)

0.314

92 (2.0%)

15 (7.3%)

3.47 (2.13–5.65)

<  0.001

7 (2.5%)

1.26 (0.61–2.60)

0.533

153 (3.3%)

21 (10.2%)

3.04 (1. 99–4.65)

<  0.001

12 (4.4%)

1.30 (0.75–2.27)

0.355

437 (9.5%)

31 (15.1%)

1.65 (1.14–2.39)

0.008

24 (8.7%)

0.92 (0.61–1.38)

0.671

25 (0.5%)

3 (1.5%)

2.53 (0.86–7.44)

0.091

1 (0.4%)

0.68 (0.10–4.66)

0.690

78 (1.7%)

5 (2.4%)

1.42 (0.60–3.35)

0.427

1 (0.4%)

0.22 (0.03–1.55)

0.089

36 (0.8%)

2 (1.0%)

1.01 (0.94–1.09)

0.760

3 (1.1%)

1.02 (0.93–1.12)

0.577

0.401

0.175

2659 (57.9%)

116 (56.6%)

174 (63.3%)

1692 (36.8%)

74 (36.1%)

90 (32.7%)

226 (4.9%)

13 (6.3%)

9 (3.3%)

16 (0.3%)

2 (1.0%)

2 (0.7%)